Results 71 to 80 of about 874,362 (147)
BACKGROUND: The Gambia introduced seven-valent pneumococcal conjugate vaccine (PCV) in August 2009 and switched to 13-valent PCV in April 2011. In April 2009 monovalent hepatitis B and combined Diphtheria-Tetanus-Pertussis and Haemophilus influenzae type
Lowe-Jallow, Y +6 more
core +1 more source
Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. [PDF]
Routine use of pneumococcal conjugate vaccines (PCVs) in developing countries is expected to lead to a significant reduction in childhood deaths. However, PCVs have been associated with replacement disease with non-vaccine serotypes.
Greenwood, Brian M +55 more
core +1 more source
Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines. [PDF]
Adamkiewicz TV +7 more
europepmc +1 more source
Pneumococcal infections and homelessness. [PDF]
Ly TDA +4 more
europepmc +1 more source
Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review. [PDF]
Cima Cabal MD +4 more
europepmc +1 more source
Pneumococcal vaccination and chronic respiratory diseases
Filipe Froes,1 Nicolas Roche,2 Francesco Blasi3,4 1Chest Department, Hospital Pulido Valente, North Lisbon Hospital Center, Lisbon, Portugal; 2Department of Respiratory and Intensive Care Medicine, Cochin Hospital, Paris Descartes University, Paris ...
Froes F, Roche N, Blasi F
doaj
Acute organ injury and long-term sequelae of severe pneumococcal infections. [PDF]
Kruckow KL +3 more
europepmc +1 more source
Background: People living with HIV (PLWH) are recognized as a high-risk population for opportunistic infections, including community-acquired pneumonia (CAP).
Reem Binsuwaidan +9 more
doaj +1 more source
Burden of illness associated with pneumococcal infections in Japan - a targeted literature review. [PDF]
Igarashi A +3 more
europepmc +1 more source
BackgroundDespite growing evidence of reduced invasive and non-invasive pneumococcal disease attributed to public health measures against the COVID-19 pandemic, the effect of these measures on pneumococcal carriage remains unclear.
Pedro Brotons +12 more
doaj +1 more source

